The Latest Thinking

The Latest Thinking


Dr. Bellmunt Shares KEYNOTE-045 Data for Pembrolizumab Versus Chemotherapy in Bladder Cancer Read More

Researchers identify early sign of pancreatic cancer Read More

Many patients with rare gastrointestinal tumor receive long-term benefit from targeted therapy, researchers report Read More